Light Therapy for Bipolar Disorder Research Study
Researchers at Massachusetts General Hospital are partnering with individuals diagnosed with bipolar disorder to evaluate how treatment with near-infrared light therapy can help. Join our compensated study today!
Fast Facts
diagnosed with bipolar disorder
currently experiencing impulsivity
18-65 years old
Compensation Provided
Conducted in Charlestown, MA
Study Background
Current medications for manic symptoms of bipolar disorder often have unpleasant side effects, and can cause further problems if you stop taking them. Modern noninvasive brain stimulation (NIBs) could provide a solution that is easier to access and more tolerable than medication. In this study, we are evaluating an investigational light therapy treatment for improving executive function in people with bipolar disorder.
Your participation in this study may help researchers improve non-invasive treatment approaches for bipolar disorder. Further research today and join our compensated study!
Study Background
Current medications for manic symptoms of bipolar disorder often have unpleasant side effects, and can cause further problems if you stop taking them. Modern noninvasive brain stimulation (NIBs) could provide a solution that is easier to access and more tolerable than medication. In this study, we are evaluating an investigational light therapy treatment for symptoms of impulsivity with bipolar disorder.
Your participation in this study may help researchers improve non-invasive treatment approaches for bipolar disorder. Further research today and join our compensated study!
Additional Information
The purpose of this research is to investigate the effect of natural, near-infrared light therapy on thinking and planning in adults with bipolar disorder. This study uses an investigational, non-invasive treatment that administers near-infrared light to the brain.
You may qualify for this study if you meet the following criteria.
Inclusion Criteria:
- Adults 18-65 years old
- Diagnosed with bipolar disorder
- Currently experiencing symptoms of impulsivity
- Willing to use adequate contraception during the study (if of child-bearing potential)
- Normal vision with contacts OR no glasses needed
Exclusion Criteria:
- Currently in a depressive, manic, or mixed episode
- Currently experiencing psychosis
- Current alcohol or substance use disorder
- Unstable medical conditions
- Unable to consent or complete study procedures
- Unsafe for MRI (e.g. claustrophobia, medical implants, other non-removable metal in the body)
- Change in medication in the last 2 weeks
- Current pregnancy
The study starts with a baseline visit. Participants then receive 5 treatment sessions, once daily for a week. The first and last treatment sessions will be administered within an MRI.
During the study visits, participants will be asked to complete cognitive tasks and mood questionnaires. There is a check-in call a few days after the final treatment, and a follow-up visit one week after conclusion of treatment.
The study can be completed in 3 weeks.
